Comparison of oxidative stress markers in type 2 diabetes: Basal bolus therapy versus twice daily premixed insulin analogs

Masaki Sakamoto, Gaku Inoue, Kaoru Tsuyusaki, Kensuke Usui, Miwako Watanabe, Junichiro Irie, Koichiro Atsuda, Satoru Yamada

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aims: Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods: In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results: There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199±92 pg/mg Cr vs 266±107 pg/mg Cr) or urinary 8-OHdG (4.7±1.6 ng/mg Cr vs 5.4±1.9 ng/mg Cr, respectively). Conclusion: These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.

Original languageEnglish
Pages (from-to)355-359
Number of pages5
JournalInternal Medicine
Volume49
Issue number5
DOIs
Publication statusPublished - 2010

Fingerprint

8-epi-prostaglandin F2alpha
Type 2 Diabetes Mellitus
Oxidative Stress
Insulin
Diabetes Complications
Therapeutics
Cross-Sectional Studies
Injections

Keywords

  • Diabetes 1
  • Insulin therapy
  • Oxidative stress

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Comparison of oxidative stress markers in type 2 diabetes : Basal bolus therapy versus twice daily premixed insulin analogs. / Sakamoto, Masaki; Inoue, Gaku; Tsuyusaki, Kaoru; Usui, Kensuke; Watanabe, Miwako; Irie, Junichiro; Atsuda, Koichiro; Yamada, Satoru.

In: Internal Medicine, Vol. 49, No. 5, 2010, p. 355-359.

Research output: Contribution to journalArticle

Sakamoto, Masaki ; Inoue, Gaku ; Tsuyusaki, Kaoru ; Usui, Kensuke ; Watanabe, Miwako ; Irie, Junichiro ; Atsuda, Koichiro ; Yamada, Satoru. / Comparison of oxidative stress markers in type 2 diabetes : Basal bolus therapy versus twice daily premixed insulin analogs. In: Internal Medicine. 2010 ; Vol. 49, No. 5. pp. 355-359.
@article{2568b4a5fdc544d580a368ac65132118,
title = "Comparison of oxidative stress markers in type 2 diabetes: Basal bolus therapy versus twice daily premixed insulin analogs",
abstract = "Aims: Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods: In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results: There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199±92 pg/mg Cr vs 266±107 pg/mg Cr) or urinary 8-OHdG (4.7±1.6 ng/mg Cr vs 5.4±1.9 ng/mg Cr, respectively). Conclusion: These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.",
keywords = "Diabetes 1, Insulin therapy, Oxidative stress",
author = "Masaki Sakamoto and Gaku Inoue and Kaoru Tsuyusaki and Kensuke Usui and Miwako Watanabe and Junichiro Irie and Koichiro Atsuda and Satoru Yamada",
year = "2010",
doi = "10.2169/internalmedicine.49.2725",
language = "English",
volume = "49",
pages = "355--359",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "5",

}

TY - JOUR

T1 - Comparison of oxidative stress markers in type 2 diabetes

T2 - Basal bolus therapy versus twice daily premixed insulin analogs

AU - Sakamoto, Masaki

AU - Inoue, Gaku

AU - Tsuyusaki, Kaoru

AU - Usui, Kensuke

AU - Watanabe, Miwako

AU - Irie, Junichiro

AU - Atsuda, Koichiro

AU - Yamada, Satoru

PY - 2010

Y1 - 2010

N2 - Aims: Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods: In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results: There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199±92 pg/mg Cr vs 266±107 pg/mg Cr) or urinary 8-OHdG (4.7±1.6 ng/mg Cr vs 5.4±1.9 ng/mg Cr, respectively). Conclusion: These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.

AB - Aims: Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods: In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results: There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199±92 pg/mg Cr vs 266±107 pg/mg Cr) or urinary 8-OHdG (4.7±1.6 ng/mg Cr vs 5.4±1.9 ng/mg Cr, respectively). Conclusion: These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.

KW - Diabetes 1

KW - Insulin therapy

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=77749321076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749321076&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.49.2725

DO - 10.2169/internalmedicine.49.2725

M3 - Article

C2 - 20190465

AN - SCOPUS:77749321076

VL - 49

SP - 355

EP - 359

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 5

ER -